Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

Certain medications commonly used to treat asthma and COPD can damage the environment and worsen respiratory issues. KYW ...

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions.

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than ... Microplastic fibers present in the ambient air can be inhaled into the lungs and promote ...

Many Part D prescription drug plans cover Trelegy Ellipta, but costs can vary by plan type and insurer. Read more.

The Hailie Smartinhaler device has also been cleared for use with inhalers from other manufacturers ... the device directly to patients with asthma and COPD under a 510(k) over-the-counter ...

Many inhalers that are vital for patients with asthma or COPD are associated with societal harms that can worsen the very diseases the products are designed to treat. How can this dilemma be resolved?

In today’s fast-paced world, respiratory health has become a significant concern for many individuals. Conditions such as ...

Delhi NCR is witnessing a sharp rise in cases of influenza, including swine flu, with many residents experiencing prolonged ...

Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.' ...